News Sentiment

BMRN sentiment intelligence

BioMarin Pharmaceutical Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 52 Balanced news tone 16 relevant articles
Exchange VIE Austria
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 51.72 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

71/100 classification confidence.

Company focus 16

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-0.8% over one week, +6.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

How FDA Review of VOXZOGO Full-Approval Data at BioMarin (BMRN) Has Changed Its Investment Story

Market Reaction

Balanced read

47/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 71/100 classification
One-week reaction -0.8% Price digesting
Trend fit Trend inactive 6.8% over four weeks
Fair value -19.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 13
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 16
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 4
PR Newswire 4
marketscreener.com 3
simplywall.st 2
Investing.com 1
Stock Titan 1
ChartMill 1

Event Lens

What the news is about

Classified themes
Market update 5
Earnings 5
Analyst action 3
Deals and strategy 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-16 of 16